Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Corvus Pharmaceuticals (CRVS) Shares Issued (2023 - 2025)

Corvus Pharmaceuticals (CRVS) has 3 years of Shares Issued data on record, last reported at $35.5 million in Q2 2025.

  • For Q2 2025, Shares Issued changed N/A year-over-year to $35.5 million; the TTM value through Sep 2025 reached $37.9 million, up 383.86%, while the annual FY2024 figure was $18.6 million, 137.03% up from the prior year.
  • Shares Issued reached $35.5 million in Q2 2025 per CRVS's latest filing, up from $279000.0 in the prior quarter.
  • Across five years, Shares Issued topped out at $35.5 million in Q2 2025 and bottomed at $4000.0 in Q1 2023.
  • Average Shares Issued over 3 years is $9.2 million, with a median of $2.2 million recorded in 2024.